MYELODYSPLASTIC SYNDROME / CHRONIC MYELOMONOCYTIC LEUKEMIA

Clinical trials for MYELODYSPLASTIC SYNDROME / CHRONIC MYELOMONOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new MYELODYSPLASTIC SYNDROME / CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME / CHRONIC MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Supercharged cord blood cells target tough blood cancers

Disease control Recruiting now

This study is testing a new cell therapy for patients whose blood cancers have returned or not responded to standard treatments. Researchers are giving patients specially engineered immune cells, called NK cells, which come from donated cord blood. The goal is to see if these mod…

Matched conditions: MYELODYSPLASTIC SYNDROME / CHRONIC MYELOMONOCYTIC LEUKEMIA

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

MYELODYSPLASTIC SYNDROME / CHRONIC MYELOMONOCYTIC LEUKEMIA

Get alerted when new MYELODYSPLASTIC SYNDROME / CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

Supercharged cord blood cells target tough blood cancers